Sunday, April 5

New Delhi – On April 2, 2026, the Rajya Sabha passed the Jan Vishwas (Amendment of Provisions) Bill, 2026, following its approval by the Lok Sabha on April 1. This landmark legislation amends 784 provisions across 79 Central Acts administered by 23 ministries to shift from a punitive, fear-driven regulatory approach to a trust-oriented system. 

News Report: Decriminalising Healthcare Compliance

Building on the 2023 Act, the 2026 Bill decriminalises 717 offences and amends over 784 provisions to improve “Ease of Doing Business” and “Ease of Living”. 

  • Key Healthcare Legislations Amended: Reforms affect critical acts, including the Drugs and Cosmetics Act (1940)Pharmacy Act (1948)Food Safety and Standards Act (2006), and Clinical Establishments Act (2010).
  • Replacement of Imprisonment: For minor technical lapses, jail terms are replaced with graded monetary penalties. For example, certain Drug and Cosmetic violations now attract fines instead of imprisonment.
  • New Adjudication Mechanism: To reduce court burdens, the Bill introduces designated adjudicating officers and appellate authorities for faster, administrative resolution of minor issues.
  • Medical Devices Industry Impact: The Association of Indian Medical Devices Industry (AiMeD) welcomed the reforms, noting they enable a focus on innovation rather than litigation.
  • Safeguarding Public Health: While minor lapses are decriminalised, strict criminal penalties remain for serious offences, such as producing spurious drugs. 
Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version